QSQi Sun

Qi Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qi Sun has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Biomimetic Nanozyme-Decoys Reprogram Immune Niches to Intercept Colitis-Carcinoma Transition

    by Qi Sun, Wanling Liu, Sijie Li, Xiwen Chen, Hanjie Zhang, Dongze Mo, Pinwen Zhou, Xiaomiao Cui, Di Huang, Bing Xia, et al.

    Colitis-associated colorectal cancer (CAC) arises from chronic inflammatory niches characterized by persistent oxidative stress and dysregulated immune cell recruitment. Current anti-inflammatory therapies provide only transient symptom relief and fail to prevent malignant progression due to their inability to simultaneously mitigate oxidative injury and immune chemotaxis. Our analysis of clinical samples revealed markedly elevated C-X-C motif chemokine ligand 2 (CXCL2) in intestinal tissues from patients with inflammatory bowel disease and CAC, implicating the CXCL2-CXCR2 (C-X-C motif chemokine receptor 2) axis in driving excessive neutrophil and macrophage infiltration and fostering tumorigenesis. Herein, we report a biomimetic nanozyme (PB@ECM) that reprograms inflammatory immune niches to intercept CAC progression. PB@ECM integrates a Prussian blue nanozyme core with genetically engineered macrophage membranes, enabling concurrent scavenging of reactive oxygen species through superoxide dismutase- and catalase-like activities and sequestration of CXCL2 via membrane-displayed CXCR2 receptors. In murine models of colitis and CAC, PB@ECM significantly alleviated intestinal inflammation, suppressed neutrophil and macrophage infiltration, and effectively inhibited colitis-carcinoma transition. Notably, treatment with PB@ECM significantly prolonged survival compared with other groups. By disrupting the pathological crosstalk between oxidative stress and immune chemotaxis, this work establishes a biomimetic nanozyme strategy for preventing inflammation-driven carcinogenesis.

  • A Theranostic Nanozyme for Osteoarthritis Treatment and Glycosaminoglycan-Targeted Diagnosis of Cartilage Pathology

    by Dongze Mo, Yanbing Wen, Chaoqun Cheng, Xiwen Chen, Qi Sun, Hanjie Zhang, Xueying An, Wanling Liu, Xiaomiao Cui, Yihong Zhang, et al.

    The lack of vascular and neural innervations in cartilage often results in poor drug delivery and penetration, compromising the efficacy of current therapeutics. To tackle this clinical challenge, we designed positively charged manganese-doped CeO2 nanozymes that combine reactive oxygen species (ROS)-scavenging activity with prolonged retention in the joint cavity by taking advantage of the negatively charged cartilage matrix. Integrating coarse-grained molecular dynamics simulations with experimental validation, we identified chondroitin sulfate as the key glycosaminoglycan responsible for mediating the retention of these positively charged nanozymes in the joint cavity. After intra-articular administration, manganese-doped CeO2 promoted cartilage defect repair and subchondral bone remodeling in a rat model within 4 weeks. In addition, benefiting from the multiple enzyme mimicking activity of nanozymes, the peroxidase-like activity of manganese-doped CeO2 was explored to develop a pathological assay to detect the state of cartilage repair. This study establishes an integrated framework combining theoretical modeling with experimental validation to elucidate intra-articular retention mechanisms. The framework enables the rational design of theranostic nanozymes that exploit disease-specific pathological features for both diagnosis and therapy.

  • Machine Learning-Assisted Nanozyme–Porphyrin Dual-Channel Sensor Array for Glycosaminoglycan Pattern Recognition

    by Sijie Li, Qing Cheng, Qi Sun, Chunfei Bao, Guangyu Bu, Shuaishuai Zhu, Yubin Ding, Hui Wei, Xiaoyu Wang

    Selective discrimination of glycosaminoglycans (GAGs) is crucial for drug safety and quality control but remains challenging because GAGs share similar disaccharide repeating units and overlapping polyanionic features. Nanozyme-based sensor arrays offer a cross-reactive fingerprinting strategy, yet many require multiple nanozymes with single readouts and correlated responses, increasing operational complexity and limiting pattern separability. Herein, we constructed a dual-channel sensor array by assembling two cationic near-infrared (NIR) porphyrins with a multifunctional Pt–Ni/rGO nanozyme that integrated efficient fluorescence quenching and oxidase-like catalysis. Upon GAG binding, each sensing element generated dual outputs, including NIR fluorescence response driven by competitive association between anionic GAGs and cationic porphyrins, and characteristic UV–vis absorption changes arising from Pt–Ni/rGO-catalyzed TMB oxidation to TMBox followed by TMBox–GAG assembly. Machine learning analysis of the four cross-reactive signals generated by the two sensing elements enabled 100% accurate discrimination of hyaluronic acid, heparin, dextran sulfate, and chondroitin sulfate in PBS over 25–500 μg/mL. Its practical utility was further demonstrated by identifying trace GAG contaminants in Hep down to 1%, classifying unknown samples, and discriminating GAGs in serum. This work expands the analytical utility of multifunctional nanozymes and provides a simple strategy for fingerprint-based GAG analysis with enhanced signal dimensionality and separability.

  • Open Access

    Nanozyme-engineered liners for proactive prevention of wear particle-induced osteolysis

    by Shujie Liu, Sheng Zhao, Qi Sun, Quanyi Liu, Yihong Zhang, Yixuan Li, Lifeng Jiang, Tong Li, Jianan Cao, Jiansen Wang, et al.

    Wear particle-induced osteolysis (WPO), primarily caused by particles generated from implants under mechanical loading, remains a major barrier to the long-term success of prosthetic implants. Traditional strategies to address WPO have largely focused on reducing wear generation, rather than mitigating the immunostimulatory effects elicited by wear particles. However, the limited scope of mechanical enhancement and the inevitable generation of wear particles shift increasing attention toward biological improvements. Herein, we propose a "proactive preventive" strategy for liner design, aiming to effectively prevent WPO by simultaneously reducing the generation of wear particles and minimizing their immunostimulatory effects. To validate the feasibility of this strategy, we synthesize a model system by incorporating ceria nanozyme into ultra-high molecular weight polyethylene (UHMWPE), referred to as CZPE. Mechanical assessments demonstrate an approximately 32% reduction in wear particle production of CZPE compared with pristine UHMWPE. Moreover, CZPE particles elicit a markedly attenuated immune response compared to PE particles in a male murine model of WPO, including reduced macrophage-mediated inflammation and diminished intramedullary plasma cell infiltration. These effects contribute to a reduction in osteoclastic bone resorption and foreign body reactions. Leveraging these mechanical and biological advantages, our approach offers a promising implant design strategy for WPO prevention.


  • Metal–Polyphenol Network Confined Synthesis of Nanozymes with Programmable Oxygen Vacancies for UVB Photodamage Therapy

    by Xiaomiao Cui, Jiawen Han, Tong Li, Wanling Liu, Qi Sun, Fuying Zhu, Congzhong Yang, Daoqing Fan, Hui Wei

    Conventional sunscreens block ultraviolet B (UVB) but fail to scavenge accumulated reactive oxygen species (ROS), causing severe photodamage. Herein, we develop a room-temperature, aqueous coordination strategy that assembles metal-polyphenol networks (MPNs) to confine in situ nucleation and growth of metal oxide nanozymes. Utilizing tannic acid coordinated ceria (CeO2-TA) as a model system, we achieve programmable regulation of surface oxygen vacancies (Ov) by adjusting the ligand-to-metal molar ratio. This process involves ligand-to-metal charge transfer (LMCT) mediated interfacial electron redistribution, resulting in significant enhancements in superoxide dismutase (SOD)- and catalase (CAT)-like activities. This "ligand-unit equivalence" design is universally applicable across diverse polyphenols, yielding highly dispersed and catalytically efficient nanozymes. In vivo, topical CeO2-TA profoundly scavenges UVB-induced ROS, mitigating acute skin inflammation and preserving the extracellular matrix against photoaging. This work establishes a universal and scalable method for the development of Ov engineered nanozymes and promotes their integration into next-generation topical sunscreens.


  • AIE Fluorescent Nanozyme-Enabled Ratiometric Sensing Platform for Selective Detection of Ascorbic Acid and Alkaline Phosphatase

    by Xiaoyu Wang, Sijie Li, Si Zhang, Qi Sun, Qing Cheng, Ke Bao, Bing Xia, Hui Wei

    Ascorbic acid (AA) and alkaline phosphatase (ALP) are essential biomolecules involved in numerous physiological and pathological processes. However, conventional nanozyme assays based on AA reduction or ALP-mediated AA generation often suffer from interference from coexisting reductants, compromising their selectivity and analytical reliability. Here, we reported a rationally designed fluorescent nanozyme, ZIF-8/Ru@TPE, constructed by anchoring ultrasmall Ru nanoparticles onto ZIF-8 and assembling them with the aggregation-induced emission (AIE) luminogen tetraphenylethylene (TPE). The resulting hybrid exhibited strong intrinsic fluorescence at 445 nm and remarkable peroxidase-like activity. Upon the addition of H2O2 and o-phenylenediamine (OPD), ZIF-8/Ru@TPE catalyzed OPD oxidation to form the fluorescent product 2,3-diaminophenazine (DAP), yielding a distinct emission peak at 570 nm while quenching the TPE fluorescence at 445 nm. Notably, AA triggered a self-amplified ratiometric response by simultaneously inhibiting OPD oxidation and generating an additional fluorophore through the reaction of dehydroascorbic acid with OPD, achieving high selectivity over other reductants. Exploiting ALP-catalyzed AA production, this platform was successfully extended to ALP activity determination in serum. This study presents a versatile nanozyme-based ratiometric sensing strategy for selective detection of AA and ALP, offering great potential for accurate bioanalysis in complex samples.


  • Open Access

    Thermodynamics-driven synthesis of phase-pure Zr-porphyrin metal–organic framework nanoparticles via auxiliary linker substitution

    by Tong Li, Xiaoyu Wang, Qi Sun, Wanling Liu, Xiaomiao Cui, Congzhong Yang, Yuting Wang, Min Zhou, Hao Dong, Hui Wei

    Metal–organic framework nanoparticles (MOF NPs) are ideal metalloenzymes mimics. Among them, peroxidase-mimicking porphyrin-based MOFs are of interest because of their stability and multifunctionality. However, identical porphyrin linkers and metal nodes like Zr6 nodes form diverse crystal phases, hindering the reliable production and practical applications of phase-pure Zr-porphyrin MOF NPs. Herein, biphenyl-4,4′-dicarboxylic acid with diverse meta-substituents (X-BPDC), including electron-donating and electron-withdrawing substituents, is used to synthesize peroxidase-mimicking PCN-224-Fe NPs. The content of PCN-224-Fe NPs in the synthesized Zr-porphyrin MOF NPs increases with an increase in the electron-withdrawing strengths, as quantified by Hammett parameters of the substituents. Critically, phase-pure PCN-224-Fe NPs are synthesized in the presence of NO2-BPDC with the strongest electron-withdrawing substituent. This synthesis protocol retains its efficacy under scaled-up conditions. Besides, this method exhibits universality: it is applicable to the synthesis of phase-pure PCN-224 NPs and PCN-224-M NPs (M = Cu, Co, and Mn) using other four porphyrin linkers.

  • Open Access

    An ultrasmall theranostic nanozyme for abdominal aortic aneurysm management and therapeutic efficacy monitoring

    by Wanling Liu, Yihong Zhang, Xiaomiao Cui, Qi Sun, Xiang Gu, Tong Li, Shicheng He, Zhexue Qin, Hui Wei

    Abdominal aortic aneurysm (AAA) is a life-threatening condition lacking effective drug interventions, and its progression is difficult to predict, complicating early clinical management. Here, we present a reactive oxygen species–responsive theranostic nanozyme for AAA early intervention and efficacy monitoring, establishing a feedback loop between treatment and diagnostics. OZn, designed by encapsulating ultrasmall Prussian blue (SPBZn) within oxidation-sensitive dextran, targets aneurysm sites, where it responds to inflammatory microenvironments by releasing SPBZn. In vivo, SPBZn not only mitigated CaCl 2 -induced aneurysm expansion and AAA progression in rat models but also enabled noninvasive diagnostic monitoring via urinalysis due to its enzymatic activities and renal metabolism. This theranostic nanozyme dynamically regulated therapeutic efficacy and provided feedback on disease progression. By preventing vascular rupture through early intervention and enabling precise drug administration, this work highlights a transformative strategy for integrating diagnostics and therapy to improve AAA management and clinical outcomes.